Thomas P. Burris

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Glenn Micalizio

New Hampshire Professor

Dartmouth College

UNITED STATES

View details

Ian Mitchelle de Vera

Assistant Professor

Saint Louis University School of Medicine

UNITED STATES

View details

Matthias Salathe

University of Kansas Medical Center

UNITED STATES

View details

Isabelle Cote

Research Assistant Professor

University of Florida

UNITED STATES

View details

Bahaa Elgendy

Associate Professor

UNITED STATES

View details

Matthew Hayes

Research Assistant Professor

University of Florida

UNITED STATES

View details

Travis Hughes

Assistant Professor

University of Montana Missoula

UNITED STATES

View details

Liming Pei

Associate Professor

University of Pennsylvania

UNITED STATES

View details

Ewa Krawczyk

Assistant Professor

Georgetown University Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas P. Burris

Research Interests

Explore related searches

Contact this professor

Articles (10)

Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function

How to Make Glucocorticoids Safer.

From Functional Fatty Acids to Potent and Selective Natural-Product-Inspired Mimetics via Conformational Profiling.

A Synthetic ERR Agonist Alleviates Metabolic Syndrome.

Rev-erbα agonists suppresses TGFβ1-induced fibroblast-to-myofibroblast transition and pro-fibrotic phenotype in human lung fibroblasts

Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity

International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023.

Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney.

Development and pharmacological evaluation of a new chemical series of potent pan-ERR agonists, identification of SLU-PP-915.

REV-ERB activation as a novel pharmacological approach for treating inflammatory pain.

Collaborators (9)

Glenn Micalizio

Ian Mitchelle de Vera

Matthias Salathe

Isabelle Cote

Bahaa Elgendy

Matthew Hayes

Travis Hughes

Liming Pei

Ewa Krawczyk

Make your next move.